FDA Safety Announcement: Asthma Drug Xolair Increases Risk of Heart and Brain Blood Vessel Problems in Children and Adults
Xolair is a dangerous prescription medication manufactured by Genentech, and intended to treat allergy related asthma in patients 12 years old to adulthood. On September 26, the FDA issued a safety announcement advising that it is making changes to the Xolair label to warn of heart and brain blood vessel problems it causes, including pulmonary […]
